MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202611000872 A) filed by Nims University, Jaipur, Rajasthan, on Jan. 5, for 'drug safety analysis system and method thereof.'
Inventor(s) include Ankit Kumar; and Gourav.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "A real-time drug interaction analysis system (100) for critical care settings, comprising a local edge device (101) configured for on-site processing, a drug interaction database (102), a patient data collector (103) for acquiring real-time clinical data, and an AI-powered analysis engine (104) for evaluating patient-specific drug interactions. The system further includes a user interface (105) for displaying analytical results, an alert subsystem (106) for issuing graded warnings, and a recommendation engine (107) for generating optimized treatment suggestions. A cloud synchronization module (108) periodically updates the database while maintaining autonomous operation, and a blockchain ledger (109) records alerts, clinician responses, and system activities with timestamps. The method (200) executed by the system collects and analyses patient data, generates alerts, provides recommendations, and synchronizes updates, thereby enabling continuous, reliable, and secure real-time drug interaction management using edge computing in critical care environments."
Disclaimer: Curated by HT Syndication.
